EG20085A - Process for preparing of imidazopyridine PAF/H2 antagonists - Google Patents
Process for preparing of imidazopyridine PAF/H2 antagonistsInfo
- Publication number
- EG20085A EG20085A EG8792A EG8792A EG20085A EG 20085 A EG20085 A EG 20085A EG 8792 A EG8792 A EG 8792A EG 8792 A EG8792 A EG 8792A EG 20085 A EG20085 A EG 20085A
- Authority
- EG
- Egypt
- Prior art keywords
- pct
- paf
- antagonists
- sec
- imidazopyridine
- Prior art date
Links
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 title 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 125000005605 benzo group Chemical group 0.000 abstract 1
- 125000006355 carbonyl methylene group Chemical group [H]C([H])([*:2])C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Prostheses (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102997A GB9102997D0 (en) | 1991-02-13 | 1991-02-13 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG20085A true EG20085A (en) | 1997-05-31 |
Family
ID=10689943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG8792A EG20085A (en) | 1991-02-13 | 1992-02-10 | Process for preparing of imidazopyridine PAF/H2 antagonists |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5358953A (enExample) |
| EP (1) | EP0572425B1 (enExample) |
| JP (1) | JP2506541B2 (enExample) |
| KR (1) | KR970005302B1 (enExample) |
| CN (1) | CN1040326C (enExample) |
| AT (1) | ATE109482T1 (enExample) |
| AU (1) | AU650322B2 (enExample) |
| BR (1) | BR9205615A (enExample) |
| CA (1) | CA2099381C (enExample) |
| CZ (1) | CZ280504B6 (enExample) |
| DE (1) | DE69200304T2 (enExample) |
| DK (1) | DK0572425T3 (enExample) |
| EG (1) | EG20085A (enExample) |
| ES (1) | ES2059212T3 (enExample) |
| FI (1) | FI933531L (enExample) |
| GB (1) | GB9102997D0 (enExample) |
| HU (2) | HUT65947A (enExample) |
| IE (1) | IE65125B1 (enExample) |
| IL (1) | IL100887A (enExample) |
| MX (1) | MX9200589A (enExample) |
| MY (1) | MY108437A (enExample) |
| NO (1) | NO300592B1 (enExample) |
| NZ (1) | NZ241597A (enExample) |
| PL (1) | PL169304B1 (enExample) |
| RU (1) | RU2114845C1 (enExample) |
| TW (1) | TW227000B (enExample) |
| WO (1) | WO1992014734A1 (enExample) |
| YU (1) | YU48238B (enExample) |
| ZA (1) | ZA921005B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2042421B1 (es) * | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
| EP0775139A1 (en) * | 1994-08-10 | 1997-05-28 | British Biotech Pharmaceuticals Limited | Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists |
| ES2087038B1 (es) * | 1994-11-07 | 1997-03-16 | Uriach & Cia Sa J | Nuevas piperidinas con actividad antagonista del paf. |
| US5866588A (en) * | 1995-04-05 | 1999-02-02 | British Biotech Pharmaceuticals Ltd. | Imidazopyridine derivatives |
| US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
| GB9508748D0 (en) * | 1995-04-28 | 1995-06-14 | British Biotech Pharm | Benzimidazole derivatives |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| CA2417960C (en) | 2000-08-04 | 2012-07-10 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| ES2579635T3 (es) | 2003-05-15 | 2016-08-12 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
| US7687515B2 (en) * | 2006-01-17 | 2010-03-30 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| AU2008349239B2 (en) | 2008-01-30 | 2012-12-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Piperidine derivative |
| JP5856843B2 (ja) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
| EP2727919B1 (en) * | 2011-06-28 | 2019-05-08 | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. | Benzocycloheptanethiophene derivatives for anti-allergic reactions |
| SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| KR102032400B1 (ko) | 2011-10-10 | 2019-10-15 | 앰피오 파마슈티컬스 인코퍼레이티드 | 퇴행성 관절 질환의 치료 |
| BR112014008036A2 (pt) * | 2011-10-28 | 2017-04-11 | Ampio Pharmaceuticals Inc | tratamento de rinite |
| CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES |
| CN113880801A (zh) * | 2020-07-03 | 2022-01-04 | 合肥医工医药股份有限公司 | 一类三环化合物、其制备方法及其医药用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL132137C (enExample) * | 1963-04-24 | |||
| JPH03503889A (ja) * | 1988-03-15 | 1991-08-29 | ジー．ディー．サール アンド カンパニー | ＰＡＦ拮抗剤としての１Ｈ／３Ｈ‐［４‐（Ｎ，Ｎ‐ジシクロアルキル／分枝アルキルカルボキサミド）‐ベンジル］イミダゾ［４，５‐ｃ］ピリジン類 |
| EP0339978B1 (en) * | 1988-04-28 | 1996-08-21 | Schering Corporation | Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents |
| US5250681A (en) * | 1988-06-02 | 1993-10-05 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| US5114919A (en) * | 1990-02-26 | 1992-05-19 | Merck & Co., Inc. | Adjuncts in cancer chemotherapy |
| JPH0678340B2 (ja) * | 1990-05-09 | 1994-10-05 | フアイザー・インコーポレイテツド | 喘息、関節炎および関連疾患の治療におけるアザベンジミダゾール |
-
1991
- 1991-02-13 GB GB919102997A patent/GB9102997D0/en active Pending
-
1992
- 1992-01-24 DK DK92902889.2T patent/DK0572425T3/da active
- 1992-01-24 DE DE69200304T patent/DE69200304T2/de not_active Expired - Fee Related
- 1992-01-24 CA CA002099381A patent/CA2099381C/en not_active Expired - Fee Related
- 1992-01-24 AU AU11683/92A patent/AU650322B2/en not_active Ceased
- 1992-01-24 RU RU93054165A patent/RU2114845C1/ru active
- 1992-01-24 BR BR9205615A patent/BR9205615A/pt not_active Application Discontinuation
- 1992-01-24 EP EP92902889A patent/EP0572425B1/en not_active Expired - Lifetime
- 1992-01-24 AT AT92902889T patent/ATE109482T1/de not_active IP Right Cessation
- 1992-01-24 FI FI933531A patent/FI933531L/fi not_active Application Discontinuation
- 1992-01-24 US US08/087,736 patent/US5358953A/en not_active Expired - Fee Related
- 1992-01-24 JP JP4503504A patent/JP2506541B2/ja not_active Expired - Fee Related
- 1992-01-24 WO PCT/EP1992/000163 patent/WO1992014734A1/en not_active Ceased
- 1992-01-24 HU HU9302327A patent/HUT65947A/hu unknown
- 1992-01-24 PL PL92300296A patent/PL169304B1/pl unknown
- 1992-01-24 KR KR1019930702352A patent/KR970005302B1/ko not_active Expired - Fee Related
- 1992-01-24 ES ES92902889T patent/ES2059212T3/es not_active Expired - Lifetime
- 1992-02-06 IL IL10088792A patent/IL100887A/en not_active IP Right Cessation
- 1992-02-10 TW TW081100891A patent/TW227000B/zh active
- 1992-02-10 EG EG8792A patent/EG20085A/xx active
- 1992-02-11 MX MX9200589A patent/MX9200589A/es unknown
- 1992-02-12 ZA ZA921005A patent/ZA921005B/xx unknown
- 1992-02-12 YU YU14392A patent/YU48238B/sh unknown
- 1992-02-12 CZ CS92425A patent/CZ280504B6/cs not_active IP Right Cessation
- 1992-02-12 NZ NZ241597A patent/NZ241597A/en unknown
- 1992-02-12 IE IE920449A patent/IE65125B1/en not_active IP Right Cessation
- 1992-02-12 MY MYPI92000223A patent/MY108437A/en unknown
- 1992-02-13 CN CN92100974A patent/CN1040326C/zh not_active Expired - Fee Related
-
1993
- 1993-08-13 NO NO932889A patent/NO300592B1/no unknown
-
1995
- 1995-06-09 HU HU95P/P00175P patent/HU211202A9/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG20085A (en) | Process for preparing of imidazopyridine PAF/H2 antagonists | |
| YU48426B (sh) | Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem | |
| MXPA02011417A (es) | 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos. | |
| ES2162061T3 (es) | Derivados de piperidina como antagonistas de la neuroquinina. | |
| YU84791A (sh) | Biciklicni 1-aza-cikloalkalni | |
| PT75471A (fr) | Procede de preparation d'ethers tricycliques | |
| AU3192195A (en) | Thiazolidinedione derivatives, their production and use | |
| RU93054165A (ru) | Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения | |
| FI922341A0 (fi) | Piperidin- och pyrrolidinderivat. | |
| EP0335979A4 (en) | Thienopyrimidine derivatives | |
| SG164268A1 (en) | Quinolin-4-yl derivatives i | |
| DE3855902D1 (de) | Herstellungsverfahren für 2,5-Diamino-6-nitro-pyridinderivate sowie neue 2,5-Diamino-6-nitro-pyridinderivate | |
| PT1018512E (pt) | Novos derivados basicos de benzo¬e|isoindol-1-onas e pirrolo¬3,4-c|quinolin-1-onas com actividade antagonista de 5ht3 a sua preparacao e o seu uso terapeutico | |
| YU4393A (sr) | Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni | |
| TW225989B (enExample) | ||
| MX9606654A (es) | Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina. | |
| GR75618B (enExample) | ||
| AU564799B2 (en) | Composition for prophylactic and preventative of ketosis in livestock | |
| HU900728D0 (en) | Process for preparation of calcium antagonistics | |
| PT100223A (pt) | Processo para a preparacao de imidazopiridinas antagonistas de paf/h1 | |
| DE69006366D1 (de) | BENZO[b]PHENANTHROLINDERIVATE, IHRE HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG. | |
| FI973558L (fi) | Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi | |
| GR70255B (enExample) | ||
| PH15866A (en) | Substituted 4-amino 2,6-diaryl-tetrahydrothiopyrans and salts thereof,and use as antidepressants | |
| HUT44502A (en) | Process for producing 3-amino-dihydropyridine derivatives and pharmaceutical compositions containing them |